Outcomes of interest in evidence-based evaluations of genetic tests. - Wikidata - wikimedia - TriplyDB

Outcomes of interest in evidence-based evaluations of genetic tests.

Outcomes of interest in evidence-based evaluations of genetic tests.

http://www.wikidata.org/entity/Q37684710

about

Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score Molecular Technologies in the Clinical Diagnostic Laboratory Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline The perspective from EASAC and FEAM on direct-to-consumer genetic testing for health-related purposes Cancer screening and genetics: a tale of two paradigms Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Evaluating genomic tests from bench to bedside: a practical framework Validation of a multiprotein plasma classifier to identify benign lung nodules Genetic testing: predictive value of genotyping for diagnosis and management of disease.Clinical utility of gene-expression profiling for tumor-site origin in patients with metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival Utility before business Consensus: a framework for evaluation of uncertain gene variants in laboratory test reporting Child and family experiences with inborn errors of metabolism: a qualitative interview study with representatives of patient groups Was it worth it? Patients' perspectives on the perceived value of genomic-based individualized medicine.Introduction to the special section on genomics.Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies.Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update.How do researchers manage genetic results in practice? The experience of the multinational Colon Cancer Family Registry.The Pursuit of Noninvasive Diagnosis of Lung Cancer.Genetic epidemiology with a capital E, ten years after.Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.Genomic medicine: a decade of successes, challenges, and opportunities.The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care.Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds.The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.Setting analytical performance specifications based on outcome studies - is it possible?Personal utility in genomic testing: a systematic literature review.Clinical utility of gene-expression signatures in early stage breast cancer.The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity.Clinical utility of genetic and genomic services: context matters.European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constitute European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

P2860

Q24621065-4F960A55-E6CA-441B-9FF2-9EB7EE846142 Q26996463-64CE406F-9282-4124-983A-486F1CDC1146 Q28079118-A9B6BFCC-1DCA-4A07-9AD2-E40145CAA925 Q30317953-FA98B507-ADF9-421F-ACD1-21AFC0FF1CE2 Q33717364-E395274D-0AEB-495E-8A9E-FCF22C8C87A6 Q33817285-7279C945-D4DF-4BD9-98CB-E11AD1EB5900 Q34451291-DE61668A-FFC6-4D51-A7E4-139BF467888E Q35241794-A6B414B3-0C94-4A4D-AF97-174E6CD462B8 Q36117915-CF646CF6-6976-4B47-9A65-DBC5DE5FC2EC Q36234056-C2665FC0-25F5-4E7D-BF73-BE928AD2903B Q36402332-E7F31307-D8B2-405A-9814-F4CA91EF079B Q36424763-628FF7B8-551A-435F-9449-1CD868BBD0FE Q36456300-36977754-D22B-43D3-9E5B-F629FEF35579 Q36698414-BF76E9CF-E33C-4CEE-BAD3-A8656EB96530 Q36944836-2BC3835D-17C5-4C92-A4E3-7046C2577FB7 Q37146388-676D500F-0D2E-4574-8110-3F60A3BE6A21 Q37590819-FD3F4ED4-E05F-438B-A221-345461D8E845 Q37598607-BA9A068D-FA03-48E7-9468-C3BEA64BAD92 Q37639436-4A6D13C2-F486-4897-83FC-AB18EACF6425 Q37652904-C9F3F794-74BA-4A37-88E1-11AC0315DB02 Q37962479-5A0C6662-C4CF-4D82-9090-D529A2094E42 Q37973386-6D9621B3-D8B1-4D55-8AD6-CE4846975C38 Q38114005-A48BF001-9467-4E72-8374-E6D150DA8C4B Q38193764-04794918-A8A7-43AA-BE01-D8A5726246C6 Q38248763-04C1EB21-27F3-4BCB-AEBA-AF1772121BB6 Q38392363-DE6413E6-3CD6-40F0-A88D-03EC182BC2F9 Q38495209-9818C560-75B3-4ABD-BFC2-ACA7F2C55A86 Q38745230-91AF6C42-BDFC-4E12-90ED-E4C79562BF2D Q38754717-9A9B1579-ACBE-4AC2-8FD0-00D5C986FB06 Q39150032-220EEB71-775E-4CBF-9520-09BE0E8BBF51 Q41936884-A68995D6-840F-4826-ADE7-404666B79F8B Q42734175-AE7E94F5-9955-4E70-A359-61E2190B773A Q48525600-1F063351-BAB3-403D-BB06-A25F5936CF78 Q48526535-9F127C5D-D854-4ED1-AD48-37829C1B50AD

P2860

Outcomes of interest in evidence-based evaluations of genetic tests.

http://www.wikidata.org/entity/Q37684710

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Outcomes of interest in evidence-based evaluations of genetic tests.

@en

Outcomes of interest in evidence-based evaluations of genetic tests.

@nl

type

label

Outcomes of interest in evidence-based evaluations of genetic tests.

@en

Outcomes of interest in evidence-based evaluations of genetic tests.

@nl

prefLabel

Outcomes of interest in evidence-based evaluations of genetic tests.

@en

Outcomes of interest in evidence-based evaluations of genetic tests.

@nl

P1433

Q37684710-0CFEE9D3-6FC7-40CC-A612-3141598311DA

P1476

Q37684710-C43D9136-962E-4558-B7C7-F371AC3C265E

P2093

Q37684710-1D0C7A26-2981-4280-9688-6C46582A53B8

Q37684710-736E081D-ECBB-43EF-85BC-057CBA17B1B5

Q37684710-7E63D009-394E-43F8-AF3A-320E1D01C011

Q37684710-BD4B6832-BD07-43E0-8F60-DB89329D6F90

Q37684710-E45BF50A-6218-470A-9BAA-5A0AF10864F0

Q37684710-E94C8EBC-0F56-4013-BCEA-7AA8AA903700

Q37684710-E97D659E-38C5-47D3-B00D-DC2A131B0E17

Q37684710-FF49BDC1-66AF-4FE5-B6BA-A4DE89BF516D

Q37684710-FFC57B39-4FBB-4CDF-A583-852BFFD1966E

P2860

Q37684710-0E8FBD62-CF2F-40EF-955D-D50450604EA6

Q37684710-1FD3522A-4D94-4161-83D9-3C9815F9DEC5

Q37684710-20A5D068-ABD9-4FE1-961F-A0989D179B2C

Q37684710-213F87ED-5DEE-41AE-B476-B147BE832C5A

Q37684710-358C4141-E9CB-4350-9C49-994B6F2C6C42

Q37684710-55985FF7-49C9-4EA6-8103-537F4DE53444

Q37684710-5BB37E1D-C8CF-4F15-8CD5-70503AE51D84

Q37684710-729DC807-7DCF-4782-AE70-6D916AD46FB2

Q37684710-7B515900-B994-4911-8320-0FD780E8B352

Q37684710-7B992202-3662-4177-8344-F6788952869E

P2888

Q37684710-49CF2E49-91AD-483F-B64D-2475E5622CAD

P304

Q37684710-55D14B67-CBFC-49D1-B126-668CBA8709E2

P31

Q37684710-D56FEE84-C32D-4432-A4FA-8245B520030E

P356

Q37684710-D0653D3F-07D1-4E5D-9FE5-D0F53016A2C5

P407

Q37684710-513A10AC-5DB8-4FE6-B82A-03E39597D457

P433

Q37684710-CD2A212D-94DB-4408-AEF2-946E9CFFFC0B

P478

Q37684710-7EDF8BD5-7526-446F-AFDE-B14609586BA2

P577

Q37684710-020853EC-9F65-44EA-B73B-4E901CBF9F9B

P6179

Q37684710-AD4D137B-25A8-4E6A-B1D3-A85C1D310F4D

P698

Q37684710-79B4E7D8-AF2A-44B2-A1EF-A98F3D333212

P356

GIM.0B013E3181CDDE04

P1433

Genetics in Medicine

P1476

Outcomes of interest in evidence-based evaluations of genetic tests.

@en

P2093

Celia I Kaye

http://www.w3.org/2001/XMLSchema#string

EGAPP Working Group

http://www.w3.org/2001/XMLSchema#string

James E Haddow

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Botkin

http://www.w3.org/2001/XMLSchema#string

Kathleen Szegda

http://www.w3.org/2001/XMLSchema#string

Linda A Bradley

http://www.w3.org/2001/XMLSchema#string

Maxine Hayes

http://www.w3.org/2001/XMLSchema#string

Steven M Teutsch

http://www.w3.org/2001/XMLSchema#string

W David Dotson

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic research and health disparities

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

The path from genome-based research to population health: development of an international public health genomics network

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium.

Current methods of the US Preventive Services Task Force: a review of the process.

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

Tay-Sachs disease screening and counseling families at risk for metabolic disease.

Genetic testing for melanoma.

Breast and ovarian cancer.

P2888

gim.0b013e3181cdde04

P304

228-235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/GIM.0B013E3181CDDE04

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1022123704

http://www.w3.org/2001/XMLSchema#string

P698

20118789

http://www.w3.org/2001/XMLSchema#string